A rational blueprint for the design of chemically-controlled protein switches.


Journal

Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555

Informations de publication

Date de publication:
01 10 2021
Historique:
received: 23 01 2021
accepted: 24 08 2021
entrez: 2 10 2021
pubmed: 3 10 2021
medline: 25 2 2023
Statut: epublish

Résumé

Small-molecule responsive protein switches are crucial components to control synthetic cellular activities. However, the repertoire of small-molecule protein switches is insufficient for many applications, including those in the translational spaces, where properties such as safety, immunogenicity, drug half-life, and drug side-effects are critical. Here, we present a computational protein design strategy to repurpose drug-inhibited protein-protein interactions as OFF- and ON-switches. The designed binders and drug-receptors form chemically-disruptable heterodimers (CDH) which dissociate in the presence of small molecules. To design ON-switches, we converted the CDHs into a multi-domain architecture which we refer to as activation by inhibitor release switches (AIR) that incorporate a rationally designed drug-insensitive receptor protein. CDHs and AIRs showed excellent performance as drug responsive switches to control combinations of synthetic circuits in mammalian cells. This approach effectively expands the chemical space and logic responses in living cells and provides a blueprint to develop new ON- and OFF-switches.

Identifiants

pubmed: 34599176
doi: 10.1038/s41467-021-25735-9
pii: 10.1038/s41467-021-25735-9
pmc: PMC8486872
doi:

Substances chimiques

Receptors, Drug 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

5754

Informations de copyright

© 2021. The Author(s).

Références

Cell. 2015 Oct 22;163(3):712-23
pubmed: 26496610
Methods Mol Biol. 2016;1414:285-304
pubmed: 27094298
Nat Commun. 2020 Oct 14;11(1):5174
pubmed: 33057059
Nat Chem Biol. 2018 Feb;14(2):112-117
pubmed: 29200207
Drugs. 2016 Jun;76(9):979-87
pubmed: 27260335
Science. 2015 Oct 16;350(6258):aab4077
pubmed: 26405231
Cell Res. 2015 Dec;25(12):1281-2
pubmed: 26575974
Acta Crystallogr D Biol Crystallogr. 2010 Feb;66(Pt 2):125-32
pubmed: 20124692
Proc Natl Acad Sci U S A. 2000 Jun 20;97(13):7096-101
pubmed: 10852943
Chem Biol. 2014 Sep 18;21(9):1102-14
pubmed: 25237857
Proc Natl Acad Sci U S A. 1992 Nov 15;89(22):10915-9
pubmed: 1438297
J Med Chem. 2015 Aug 27;58(16):6348-58
pubmed: 26181851
Nat Rev Mol Cell Biol. 2018 Aug;19(8):507-525
pubmed: 29858606
N Engl J Med. 2016 Jan 28;374(4):311-22
pubmed: 26639348
ACS Med Chem Lett. 2014 Aug 26;5(10):1088-93
pubmed: 25313317
Nat Med. 2013 Feb;19(2):202-8
pubmed: 23291630
Cancer Res. 2015 Sep 1;75(17):3505-18
pubmed: 26330164
Nat Chem Biol. 2018 Jul;14(7):723-729
pubmed: 29686358
Proc Natl Acad Sci U S A. 2015 Jan 20;112(3):749-54
pubmed: 25552560
Nat Struct Biol. 2003 Jan;10(1):45-52
pubmed: 12459719
Cell. 2016 Oct 6;167(2):419-432.e16
pubmed: 27693353
Pflugers Arch. 2013 Mar;465(3):409-17
pubmed: 23299847
Biol Blood Marrow Transplant. 2010 Sep;16(9):1245-56
pubmed: 20304086
PLoS One. 2011;6(6):e20161
pubmed: 21731610
J Mol Biol. 1987 Aug 5;196(3):641-56
pubmed: 3681970
Curr Opin Chem Biol. 2018 Jun;44:75-86
pubmed: 29908451
Angew Chem Int Ed Engl. 2015 Dec 14;54(51):15410-3
pubmed: 26768531
Nat Biotechnol. 2020 Apr;38(4):426-432
pubmed: 32015549
Cell. 2013 Aug 15;154(4):928-39
pubmed: 23953120
Science. 2000 Feb 4;287(5454):826-30
pubmed: 10657290
J Hematol Oncol. 2017 Jul 3;10(1):133
pubmed: 28673313
Nat Biotechnol. 2019 Oct;37(10):1209-1216
pubmed: 31501561
Curr Opin Biotechnol. 2018 Aug;52:145-152
pubmed: 29729544
Science. 2018 Mar 9;359(6380):
pubmed: 29590011
Blood. 2012 May 3;119(18):4133-41
pubmed: 22354001
NPJ Syst Biol Appl. 2019 Jul 18;5:23
pubmed: 31341635
Diabetes. 2013 Aug;62(8):2674-82
pubmed: 23881200
Acta Crystallogr D Biol Crystallogr. 2010 Apr;66(Pt 4):486-501
pubmed: 20383002
Science. 2020 Oct 16;370(6514):321-327
pubmed: 33060356
Methods Mol Biol. 2017;1529:291-306
pubmed: 27914058
Cell Death Differ. 2009 Jan;16(1):46-56
pubmed: 18636076
Acta Crystallogr D Biol Crystallogr. 2010 Feb;66(Pt 2):213-21
pubmed: 20124702
J Mol Biol. 2006 May 5;358(3):829-45
pubmed: 16545842
Blood. 2006 Mar 15;107(6):2294-302
pubmed: 16282341
N Engl J Med. 2011 Nov 3;365(18):1673-83
pubmed: 22047558
Proc Natl Acad Sci U S A. 2000 Sep 12;97(19):10383-8
pubmed: 10984534
PLoS Comput Biol. 2017 Jun 12;13(6):e1005600
pubmed: 28604768
Proc Natl Acad Sci U S A. 2010 Aug 3;107(31):13707-12
pubmed: 20643959
Nat Med. 1996 Feb;2(2):216-23
pubmed: 8574968
J Appl Crystallogr. 2007 Aug 1;40(Pt 4):658-674
pubmed: 19461840
J Biol Chem. 1995 May 19;270(20):11962-9
pubmed: 7744846
Science. 2019 Nov 22;366(6468):1024-1028
pubmed: 31754004

Auteurs

Sailan Shui (S)

Laboratory of Protein Design and Immunoengineering (LPDI) - STI - EPFL, Lausanne, Switzerland.
Swiss Institute of Bioinformatics (SIB), Lausanne, CH-1015, Switzerland.

Pablo Gainza (P)

Laboratory of Protein Design and Immunoengineering (LPDI) - STI - EPFL, Lausanne, Switzerland.
Swiss Institute of Bioinformatics (SIB), Lausanne, CH-1015, Switzerland.

Leo Scheller (L)

Laboratory of Protein Design and Immunoengineering (LPDI) - STI - EPFL, Lausanne, Switzerland.
Swiss Institute of Bioinformatics (SIB), Lausanne, CH-1015, Switzerland.

Che Yang (C)

Laboratory of Protein Design and Immunoengineering (LPDI) - STI - EPFL, Lausanne, Switzerland.
Swiss Institute of Bioinformatics (SIB), Lausanne, CH-1015, Switzerland.

Yoichi Kurumida (Y)

Department of Life Science, School and Graduate School of Bioscience and Biotechnology, Tokyo Institute of Technology, Meguro-ku, Tokyo, 152-8550, Japan.

Stéphane Rosset (S)

Laboratory of Protein Design and Immunoengineering (LPDI) - STI - EPFL, Lausanne, Switzerland.
Swiss Institute of Bioinformatics (SIB), Lausanne, CH-1015, Switzerland.

Sandrine Georgeon (S)

Laboratory of Protein Design and Immunoengineering (LPDI) - STI - EPFL, Lausanne, Switzerland.
Swiss Institute of Bioinformatics (SIB), Lausanne, CH-1015, Switzerland.

Raphaël B Di Roberto (RB)

Department of Biosystems Science and Engineering, ETH Zürich, 4058, Basel, Switzerland.

Rocío Castellanos-Rueda (R)

Department of Biosystems Science and Engineering, ETH Zürich, 4058, Basel, Switzerland.

Sai T Reddy (ST)

Department of Biosystems Science and Engineering, ETH Zürich, 4058, Basel, Switzerland.

Bruno E Correia (BE)

Laboratory of Protein Design and Immunoengineering (LPDI) - STI - EPFL, Lausanne, Switzerland. bruno.correia@epfl.ch.
Swiss Institute of Bioinformatics (SIB), Lausanne, CH-1015, Switzerland. bruno.correia@epfl.ch.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH